We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NAV market cap is 403.5k. The company's latest EPS is CAD -0.0532 and P/E is -0.19.
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -185k | 0 | 0 | -1,000 | -347k |
Net Income | -185k | -49k | -74k | -94k | -2.15M |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 231k | 181k | 116k | 112k | 931k |
Total Liabilities | 21k | 20k | 18k | 109k | 844k |
Total Equity | 210k | 161k | 98k | 3k | 87k |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -89k | -48k | -81k | -10k | -1.78M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 271k | 25k | -88k | N/A | 2.01M |
Market Cap | 403.5k |
Price to Earnings Ratio | -0.19 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.72 |
Price to Book Ratio | 4.64 |
Dividend Yield | - |
Shares Outstanding | 40.35M |
Average Volume (1 week) | 250 |
Average Volume (1 Month) | 9.51k |
52 Week Change | -75.00% |
52 Week High | 0.115 |
52 Week Low | 0.01 |
Spread (Intraday) | 0.01 (33.33%) |
Company Name | NAVCO Pharmaceuticals Inc |
Address |
5205 harvester road, unit 1 burlington, ontario L7L 6B5 |
Website | https://navcopharma.com |
Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions